London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
Oxford Nanopore Technologies
Hagar Mor-Shaked
- Job title
- Institution
- Hadassah Medical Center, Israel
- Biography
Hagar Mor-Shaked is the head of the next-generation sequencing (NGS) analysis team at Hadassah, Principal Investigator at the Faculty of Medicine, Hebrew University, and Chief Product Officer of Geneyx. Hagar is one of the leading and most experienced clinical genetic experts in Israel. She is an esteemed clinical genetic analyst, with over 10 years of experience in molecular genetics, genomics, and bioinformatics in a clinical and academic setting. As head of bioinformatics at the genetic department of Hadassah-Hebrew University Medical Center, she gained expertise in using different NGS methodologies for diagnosing rare diseases, analyzed thousands of clinical exome and genome sequencing tests, and established the largest genomic database in Israel. In addition, Hagar has published dozens of high-quality academic papers. Hagar holds an MSc in genetic counseling and a PhD in human genetics from the Hebrew University of Jerusalem.
- Recent publications
Rips, J. et al. Long-read whole-genome sequencing uncovers a deletion upstream to HOXD13 causing synpolydactyly. Am. J. Med. Genet. A. 197(10):e64130 (2025).
DOI: 10.1002/ajmg.a.64130
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
